Literature DB >> 27313859

Keratin 19-positive cutaneous squamous cell carcinoma with elevated serum cytokeratin 19 fragment 21-1 level: A case report.

Misato Ueda1, Michinori Yasuda1, Yoshie Shibaoka1, Ichiro Kurokawa2, Ayako Kakuno3, Airo Tsubura4.   

Abstract

cytokeratin 19 fragment 21-1 (CYFRA21-1) is a marker of lung cancer useful for evaluating clinical diagnosis and prognosis. To the best of our knowledge, there have been no reports of cutaneous squamous cell carcinoma (SCC) with high levels of CYFRA21-1 to date. We herein report a case of a 79-year-old man with a large subcutaneous tumor of the left shoulder, which was diagnosed as primary cutaneous poorly differentiated SCC. The tumor nests were composed of poorly differentiated atypical squamous cells exhibiting high-grade malignancy and mitotic figures; multinuclear cells were also identified inside lymph vessels. Keratin 19 (K19) was intensely expressed in tumor cells. A significantly elevated level of CYFRA21-1 (33 ng/ml) was observed preoperatively. After surgery, the level of CYFRA21-1 was significantly decreased (from 33 to 5.0 ng/ml). Our case demonstrated that K19-positive primary cutaneous undifferentiated SCC induced high levels of CYFRA21-1 in the serum. Thus, CYFRA 21-1 may be a marker indicative of poorly differentiated cutaneous SCC exhibiting K19 expression.

Entities:  

Keywords:  cytokeratin 19 fragment 21-1; keratin 19; primary cutaneous squamous cell carcinoma

Year:  2016        PMID: 27313859      PMCID: PMC4888029          DOI: 10.3892/mco.2016.834

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  6 in total

1.  Trichilemmoma: an immunohistochemical study of cytokeratins.

Authors:  I Kurokawa; S Nishijima; K Kusumoto; H Senzaki; N Shikata; A Tsubura
Journal:  Br J Dermatol       Date:  2003-07       Impact factor: 9.302

Review 2.  CYFRA 21-1--clinical applications and analytical requirements.

Authors:  W Ebert; H Bodenmüller; W Hölzel
Journal:  Scand J Clin Lab Invest Suppl       Date:  1995

3.  Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia.

Authors:  A C Markey; E B Lane; L J Churchill; D M MacDonald; I M Leigh
Journal:  J Invest Dermatol       Date:  1991-11       Impact factor: 8.551

Review 4.  Expression of keratins in cutaneous epithelial tumors and related disorders--distribution and clinical significance.

Authors:  Ichiro Kurokawa; Kenzo Takahashi; Ingrid Moll; Roland Moll
Journal:  Exp Dermatol       Date:  2011-03       Impact factor: 3.960

5.  Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines.

Authors:  G A Blobel; R Moll; W W Franke; I Vogt-Moykopf
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

Review 6.  The human keratins: biology and pathology.

Authors:  Roland Moll; Markus Divo; Lutz Langbein
Journal:  Histochem Cell Biol       Date:  2008-05-07       Impact factor: 4.304

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.